Pharmaceuticals in Japan

Date: September 26, 2016
Pages: 38
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P4124EA33C6EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Japan
SUMMARY

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Japan pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Japan pharmaceuticals market by value in 2015?
  • What will be the size of the Japan pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Japan pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Japan's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Japanese pharmaceuticals market had total revenues of $81.2bn in 2015, representing a compound annual growth rate (CAGR) of 3.9% between 2011 and 2015.

In Japan, every citizen is required to participate in the National Health Insurance (NHI) scheme and the majority of health care spending is publically funded through this and other government funds.

The performance of the market is forecast to decelerate, with an anticipated CAGR of 0.1% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $81.7bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Astellas Pharma GmbH
Astellas Pharma GmbH
Daiichi Sankyo Co., Ltd.
Takeda Pharmaceutical Company Limited
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Japan pharmaceuticals market value: $ billion, 2011-15
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Japan pharmaceuticals market share: % share, by value, 2015
Table 4: Japan pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Astellas Pharma GmbH: key facts
Table 6: Astellas Pharma GmbH: key financials ($)
Table 7: Astellas Pharma GmbH: key financials (¥)
Table 8: Astellas Pharma GmbH: key financial ratios
Table 9: Astellas Pharma GmbH: key facts
Table 10: Astellas Pharma GmbH: key financials ($)
Table 11: Astellas Pharma GmbH: key financials (¥)
Table 12: Astellas Pharma GmbH: key financial ratios
Table 13: Daiichi Sankyo Co., Ltd.: key facts
Table 14: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 15: Daiichi Sankyo Co., Ltd.: key financials (¥)
Table 16: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 17: Takeda Pharmaceutical Company Limited: key facts
Table 18: Takeda Pharmaceutical Company Limited: key financials ($)
Table 19: Takeda Pharmaceutical Company Limited: key financials (¥)
Table 20: Takeda Pharmaceutical Company Limited: key financial ratios
Table 21: Japan size of population (million), 2011-15
Table 22: Japan gdp (constant 2005 prices, $ billion), 2011-15
Table 23: Japan gdp (current prices, $ billion), 2011-15
Table 24: Japan inflation, 2011-15
Table 25: Japan consumer price index (absolute), 2011-15
Table 26: Japan exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Japan pharmaceuticals market value: $ billion, 2011-15
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Japan pharmaceuticals market share: % share, by value, 2015
Figure 4: Japan pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Japan, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Japan, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Japan, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2015
Figure 11: Astellas Pharma GmbH: revenues and profitability
Figure 12: Astellas Pharma GmbH: assets and liabilities
Figure 13: Astellas Pharma GmbH: revenues and profitability
Figure 14: Astellas Pharma GmbH: assets and liabilities
Figure 15: Daiichi Sankyo Co., Ltd.: revenues and profitability
Figure 16: Daiichi Sankyo Co., Ltd.: assets and liabilities
Figure 17: Takeda Pharmaceutical Company Limited: revenues and profitability
Figure 18: Takeda Pharmaceutical Company Limited: assets and liabilities

COMPANIES MENTIONED

Astellas Pharma GmbH
Astellas Pharma GmbH
Daiichi Sankyo Co., Ltd.
Takeda Pharmaceutical Company Limited
Skip to top


OTC Pharmaceuticals in Japan US$ 350.00 Sep, 2016 · 35 pages
The Pharmaceutical Market: Japan US$ 1,295.00 Jan, 2013 · 99 pages

Ask Your Question

Pharmaceuticals in Japan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: